{"id":"https://openalex.org/W3165901437","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.e19545","title":"Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse.","display_name":"Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse.","publication_year":2021,"publication_date":"2021-05-20","ids":{"openalex":"https://openalex.org/W3165901437","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.e19545","mag":"3165901437"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.15_suppl.e19545","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.e19545","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.e19545","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003314025","display_name":"Brett Barlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett Barlow","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003613574","display_name":"Haris Hatic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haris Hatic","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075444717","display_name":"Charles Douglas Bodine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Douglas Bodine","raw_affiliation_strings":["UAB, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UAB, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030631799","display_name":"Amitkumar Mehta","orcid":"https://orcid.org/0000-0003-0537-4207","observed_orcids":["https://orcid.org/0000-0003-0537-4207"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039376","display_name":"O'Neal Comprehensive Cancer Center","ror":"https://ror.org/03j18km61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250","https://openalex.org/I4390039376"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amitkumar Mehta","raw_affiliation_strings":["O\u2019Neal Comprehensive Cancer Center at The University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O\u2019Neal Comprehensive Cancer Center at The University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039376"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056210769","display_name":"Gaurav Goyal","orcid":"https://orcid.org/0000-0001-6148-5177","observed_orcids":["https://orcid.org/0000-0001-6148-5177"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gaurav Goyal","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004490449","display_name":"Mayur Subhash Narkhede","orcid":"https://orcid.org/0000-0002-2606-0533","observed_orcids":["https://orcid.org/0000-0002-2606-0533"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mayur Narkhede","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"15_suppl","first_page":"e19545","last_page":"e19545"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8515999913215637,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8515999913215637,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.12189999967813492,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.6110000014305115},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.8109999895095825},{"id":"https://openalex.org/keywords/r-epoch","display_name":"R-EPOCH","score":0.9940000176429749},{"id":"https://openalex.org/keywords/r-minichop","display_name":"R-miniCHOP","score":0.8619999885559082},{"id":"https://openalex.org/keywords/central-nervous-system-diseases","display_name":"central nervous system disorders","score":0.6629999876022339},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.8180000185966492},{"id":"https://openalex.org/keywords/treatment-delay","display_name":"treatment delay","score":0.6489999890327454},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6420000195503235},{"id":"https://openalex.org/keywords/methotrexate-clearance","display_name":"methotrexate clearance","score":0.7139999866485596},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9226059913635254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6707412004470825},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6162923574447632},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5414375066757202},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5328733325004578},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.5292838215827942},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4839380383491516},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.46653157472610474},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.45324790477752686},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.4351847767829895},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.4216885566711426},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4210447072982788},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3714892864227295},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33526837825775146},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3126062750816345}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.15_suppl.e19545","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.e19545","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.e19545","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3173582503","https://openalex.org/W3047361396","https://openalex.org/W4205858886","https://openalex.org/W7216549597","https://openalex.org/W2950886764","https://openalex.org/W4380080950","https://openalex.org/W3165803375","https://openalex.org/W2950721348","https://openalex.org/W3000527533","https://openalex.org/W4379981689"],"abstract_inverted_index":{"e19545":[0],"Background:":[1],"High-dose":[2],"methotrexate":[3],"(HD-MTX)":[4],"at":[5,31,133,148],"a":[6],"dose":[7],"between":[8],"2.5":[9],"to":[10,22,55,166],"5":[11],"gm/m2":[12],"is":[13,58],"commonly":[14],"administered":[15,107],"in":[16,53,80,242,254],"conjunction":[17],"with":[18,24,67,72,86,105,126,128,206,215,219,245,275,281,284,288,308],"standard":[19],"induction":[20,56],"chemotherapy":[21,57],"patients":[23,124,243],"Diffuse":[25],"Large":[26],"B":[27],"Cell":[28],"Lymphoma":[29,44],"(DLBCL)":[30],"high":[32,134],"risk":[33,135],"of":[34,51,88,111,113,136,146,182,192,237,262,269,292,300],"central":[35],"nervous":[36],"system":[37],"(CNS)":[38],"relapse,":[39],"as":[40],"defined":[41],"by":[42],"the":[43,99,180,190,267,298],"International":[45],"Prognostic":[46],"Index":[47],"(CNS-IPI).":[48],"Optimal":[49],"timing":[50],"HD-MTX":[52,65,106,178,188,205,278,311],"relation":[54],"unknown.":[59],"A":[60],"recent":[61],"study":[62,97,121],"suggested":[63],"that":[64,266],"intercalated":[66,289],"R-CHOP":[68,183,248],"cycles":[69,112],"was":[70,152,217,239],"associated":[71,104,218],"increased":[73],"toxicity":[74],"and":[75,101,157,162,171,199,201,230,271,304],"treatment":[76,89,102,163,172,225,272,293,301],"delays":[77,103,226,273],"without":[78],"improvement":[79],"survival":[81],"or":[82,132,290],"CNS":[83,130,137],"relapse":[84,138],"compared":[85],"end":[87,291],"MTX":[90,142,167,214,294],"(Wilson":[91],"et":[92],"al":[93],"2020).":[94],"This":[95,116],"retrospective":[96,119],"evaluates":[98],"toxicities":[100,169,238,270,303],"on":[108,143,179,189],"day":[109,144,181,191,212,277,310],"1":[110,145],"chemo-immunotherapy.":[114],"Methods:":[115],"single":[117],"center":[118],"cohort":[120],"included":[122,158],"45":[123],"(pts)":[125],"DLBCL":[127],"concurrent":[129],"disease":[131],"who":[139],"received":[140,177,187,204],"HD":[141,213],"chemo-immunotherapy":[147,216],"our":[149,259],"center.":[150],"Data":[151],"abstracted":[153],"from":[154],"chart":[155],"review":[156],"variables":[159],"describing":[160],"clinical":[161],"characteristics,":[164],"time":[165],"clearance,":[168],"experienced":[170,274],"delays.":[173],"Results:":[174],"31":[175],"pts":[176,186,203],"chemotherapy,":[184],"6":[185],"R-EPOCH":[193,246,282],"(Rituximab,":[194],"Etoposide,":[195],"Doxorubicin,":[196],"Vincristine,":[197],"Cyclophosphamide,":[198],"Prednisone),":[200],"8":[202],"R-MiniCHOP":[207],"(dose":[208],"reduced":[209],"R-CHOP).":[210],"Same":[211],"acute":[220],"kidney":[221],"injury":[222],"(AKI;":[223],"17-25%),":[224],">7":[227],"days":[228],"(13-17%),":[229],"grade":[231],"2":[232],"mucositis":[233],"(11-50%).":[234],"The":[235],"burden":[236],"numerically":[240],"higher":[241,280,307],"treated":[244],"vs.":[247],"(Table).":[249],"Clinical":[250],"outcomes":[251],"are":[252,279,306],"summarized":[253],"table":[255],"below.":[256],"Conclusions:":[257],"In":[258],"heterogeneous":[260],"population":[261],"pts,":[263],"we":[264],"describe":[265],"incidence":[268,299],"same":[276,309],"than":[283],"R-CHOP.":[285],"Comparative":[286],"studies":[287],"will":[295],"determine":[296],"if":[297],"delays,":[302],"de-escalations":[305],"administration.":[312],"[Table:":[313],"see":[314],"text]":[315]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-06-22T00:00:00"}